semaglutide provider near me biloxi Compounded Ozempic® & Wegovy® Weight-Loss Injections

Hawaii 5% Full List of GLP-1 Map State-by-State | Alphabetical Order Alabama Number of Prescriptions (2024) : 993,406 Increase from 2023: 0.4% Statewide GLP-1 Usage: 19% Alaska Number of Prescriptions (2024) : 128,658 Increase from 2023: 21.8% Statewide GLP-1 Usage: 17% Arizona Number of Prescriptions (2024) : 614,174 Increase from 2023: 12.6% Statewide GLP-1 Usage: 8% Arkansas Number of Prescriptions (2024) : 535,706 Increase from 2023: -1.4% Statewide GLP-1 Usage: 17% California Number of Prescriptions (2024) : 3,731,277 Increase from 2023: 5.4% Statewide GLP-1 Usage: 9.5% Colorado Number of Prescriptions (2024) : 464,404 Increase from 2023: 17.2% Statewide GLP-1 Usage: 8% Connecticut Number of Prescriptions (2024) : 482,518 Increase from 2023: 12.7% Statewide GLP-1 Usage: 13% Delaware Number of Prescriptions (2024) : 114,101 Increase from 2023: 4.7% Statewide GLP-1 Usage: 11% District of Columbia (Washington D.C.) Number of Prescriptions (2024) : DATA NOT PROVIDED Increase from 2023: DATA NOT PROVIDED Statewide GLP-1 Usage: DATA NOT PROVIDED Florida Number of Prescriptions (2024) : 2,428,469 Increase from 2023: 23.7% Statewide GLP-1 Usage: 10% Georgia Number of Prescriptions (2024) : 1,705,031 Increase from 2023: 11.1% Statewide GLP-1 Usage: 15% Hawaii Number of Prescriptions (2024) : 73,037 Increase from 2023: 21% Statewide GLP-1 Usage: 5% Idaho Number of Prescriptions (2024) : 289,031 Increase from 2023: -11% Statewide GLP-1 Usage: 14% Illinois Number of Prescriptions (2024) : 1,638,601 Increase from 2023: 13.8% Statewide GLP-1 Usage: 13% Indiana Number of Prescriptions (2024) : 879,327 Increase from 2023: 0.8% Statewide GLP-1 Usage: 13% Iowa Number of Prescriptions (2024) : 527,261 Increase from 2023: 14.4% Statewide GLP-1 Usage: 16.5% Kansas Number of Prescriptions (2024) : 455,116 Increase from 2023: 7.4% Statewide GLP-1 Usage: 15% Kentucky Number of Prescriptions (2024) : 1,009,621 Increase from 2023: 2.6% Statewide GLP-1 Usage: 22% Louisiana Number of Prescriptions (2024) : 932,534 Increase from 2023: -11.6% Statewide GLP-1 Usage: 20% Maine Number of Prescriptions (2024) : 178,725 Increase from 2023: 27.2% Statewide GLP-1 Usage: 13% Maryland Number of Prescriptions (2024) : 604,082 Increase from 2023: 22.6% Statewide GLP-1 Usage: 10% Massachusetts Number of Prescriptions (2024) : 777,322 Increase from 2023: 48% Statewide GLP-1 Usage: 11% Michigan Number of Prescriptions (2024) : 1,600,221 Increase from 2023: 5.4% Statewide GLP-1 Usage: 16% Minnesota Number of Prescriptions (2024) : 622,770 Increase from 2023: 13% Statewide GLP-1 Usage: 11% Mississippi Number of Prescriptions (2024) : 551,702 Increase from 2023: 2% Statewide GLP-1 Usage: 19% Missouri Number of Prescriptions (2024) : 872,356 Increase from 2023: 7.2% Statewide GLP-1 Usage: 14% Montana Number of Prescriptions (2024) : 126,175 Increase from 2023: 7.3% Statewide GLP-1 Usage: 11.5% Nebraska Number of Prescriptions (2024) : 271,949 Increase from 2023: 9% Statewide GLP-1 Usage: 14% Nevada Number of Prescriptions (2024) : 242,809 Increase from 2023: 5.1% Statewide GLP-1 Usage: 8% New Hampshire Number of Prescriptions (2024) : 158,953 Increase from 2023: 15.3% Statewide GLP-1 Usage: 11% New Jersey Number of Prescriptions (2024) : 1,334,806 Increase from 2023: 35.8% Statewide GLP-1 Usage: 14% New Mexico Number of Prescriptions (2024) : 260,260 Increase from 2023: 20.4% Statewide GLP-1 Usage: 12% New York Number of Prescriptions (2024) : 2,820,519 Increase from 2023: 15.1% Statewide GLP-1 Usage: 14% North Carolina Number of Prescriptions (2024) : 1,362,471 Increase from 2023: 5.7% Statewide GLP-1 Usage: 13% North Dakota Number of Prescriptions (2024) : 142,108 Increase from 2023: 20.8% Statewide GLP-1 Usage: 18% Ohio Number of Prescriptions (2024) : 1,694,075 Increase from 2023: 6.9% Statewide GLP-1 Usage: 14.5% Oklahoma Number of Prescriptions (2024) : 798,802 Increase from 2023: 16.8% Statewide GLP-1 Usage: 20% Oregon Number of Prescriptions (2024) : 338,387 Increase from 2023: 12.6% Statewide GLP-1 Usage: 8% Pennsylvania Number of Prescriptions (2024) : 2,240,537 Increase from 2023: 8.8% Statewide GLP-1 Usage: 17% Rhode Island Number of Prescriptions (2024) : 83,436 Increase from 2023: 67.8% Statewide GLP-1 Usage: 7.5% South Carolina Number of Prescriptions (2024) : 745,836 Increase from 2023: 9.3% Statewide GLP-1 Usage: 13.5% South Dakota Number of Prescriptions (2024) : 100,533 Increase from 2023: -11.1% Statewide GLP-1 Usage: 11% Tennessee Number of Prescriptions (2024) : 1,076,487 Increase from 2023: 4.2% Statewide GLP-1 Usage: 15% Texas Number of Prescriptions (2024) : 4,664,860 Increase from 2023: 4.8% Statewide GLP-1 Usage: 15% Utah Number of Prescriptions (2024) : 299,074 Increase from 2023: 6.2% Statewide GLP-1 Usage: 8% Vermont Number of Prescriptions (2024) : 74,681 Increase from 2023: -1.7% Statewide GLP-1 Usage: 12% Virginia Number of Prescriptions (2024) : 1,029,811 Increase from 2023: 9% Statewide GLP-1 Usage: 12% Washington Number of Prescriptions (2024) : 717,454 Increase from 2023: 8.4% Statewide GLP-1 Usage: 9% West Virginia Number of Prescriptions (2024) : 428,637 Increase from 2023: -3.2% Statewide GLP-1 Usage: 24% Wisconsin Number of Prescriptions (2024) : 594,805 Increase from 2023: 21.8% Statewide GLP-1 Usage: 10% Wyoming Number of Prescriptions (2024) : 71,942 Increase from 2023: 17.1% Statewide GLP-1 Usage: 12% How Much Will the GLP-1 Map Change in 2025

The recommended dosages are based on the data from clinical trials for that specific use. For both types, higher doses may lead to negative side effects Increasing the dosage for both types of medications can come with negative side effects (nausea, vomiting, constipation, fatigue, loss of appetite and more)

Australians experienced a particularly severe Ozempic shortage recently

No studies have confirmed a link between GLP-1 medications and thyroid tumors in humans, but if you have a history of family thyroid cancer, you may want to discuss taking a GLP-1 with your primary care provider

Until more data is available, its best to exercise caution and consult with your healthcare provider about the timing of discontinuation if youre planning to conceive

counseling, peer support groups (e.g., Amputee Coalition), and rehabilitation psychology support are available CDI / Coding Summary Audit Alert Amputation Coding Checklist For every amputation-related encounter, verify: Status vs